Table 2 Spearman’s rho correlation between plasma p-Tau217 and CSF biomarkers in AD and non-AD groups.

From: Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unit

 

AD

Non-AD

Plasma p-Tau217 (pg mL−1)

Rho (p value)

Plasma p-Tau217 (pg mL−1)

Rho (p value)

CSF Aβ42 (pg mL−1)

− 0.082 (> 0.05)

− 0.048 (> 0.05)

CSF Aβ40 (pg mL−1)

0.009 (> 0.05)

0.133 (> 0.05)

CSF Aβ42/Aβ40

− 0.119 (> 0.05)

− 0.224 (0.01*)

CSF p-Tau181 (pg mL−1)

0.554 (< 0.001*)

0.370 (< 0.001*)

CSF t-Tau (pg mL−1)

0.503 (< 0.001*)

0.337 (< 0.001*)

CSF t-Tau/Aβ42

0.493 (< 0.001*)

0.391 (< 0.001*)

CSF NfL (pg mL−1)

0.302 (< 0.001*)

0.335 (< 0.001*)

  1. *P < 0.05.
Back to article page